Ligase Complex Activity via the EDD-DDB1-VPRBP E3 HIV-1 Vpr Protein Inhibits Telomerase

[1]  Xin Wang,et al.  Dyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation* , 2013, The Journal of Biological Chemistry.

[2]  Andrej Sali,et al.  Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection , 2011, Nature.

[3]  B. Sobhian,et al.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.

[4]  M. Washburn,et al.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.

[5]  S. Deeks,et al.  HIV infection, inflammation, immunosenescence, and aging. , 2011, Annual review of medicine.

[6]  M. Kogan,et al.  HIV-1 Accessory Protein Vpr: Relevance in the pathogenesis of HIV and potential for therapeutic intervention , 2011, Retrovirology.

[7]  Timothy D. Veenstra,et al.  Telomerase modulates Wnt signalling by association with target gene chromatin , 2009, Nature.

[8]  Junjie Chen,et al.  Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase. , 2009, Nature cell biology.

[9]  C. Harley,et al.  Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes1 , 2008, The Journal of Immunology.

[10]  L. Zon,et al.  A Non-Canonical Function of Zebrafish Telomerase Reverse Transcriptase Is Required for Developmental Hematopoiesis , 2008, PloS one.

[11]  F. Margottin-Goguet,et al.  Assembly with the Cul4A-DDB1DCAF1 Ubiquitin Ligase Protects HIV-1 Vpr from Proteasomal Degradation* , 2008, Journal of Biological Chemistry.

[12]  J. Chen,et al.  VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation , 2008, Oncogene.

[13]  M. Lako,et al.  A Key Role for Telomerase Reverse Transcriptase Unit in Modulating Human Embryonic Stem Cell Proliferation, Cell Cycle Dynamics, and In Vitro Differentiation , 2008, Stem cells.

[14]  Xiao-Fang Yu,et al.  DDB1 and Cul4A Are Required for Human Immunodeficiency Virus Type 1 Vpr-Induced G2 Arrest , 2007, Journal of Virology.

[15]  A. Finzi,et al.  HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1-CUL4AVPRBP E3 Ubiquitin Ligase , 2007, PLoS pathogens.

[16]  E. Bonmassar,et al.  Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4+ T lymphocytes infected with human immunodeficiency virus type 1 (HIV‐1) , 2007, Journal of medical virology.

[17]  Jean-Christophe Rain,et al.  HIV1 Vpr Arrests the Cell Cycle by Recruiting DCAF1/VprBP, a Receptor of the Cul4-DDB1 Ubiquitin Ligase , 2007, Cell cycle.

[18]  C. Autexier,et al.  The structure and function of telomerase reverse transcriptase. , 2006, Annual review of biochemistry.

[19]  H. Salomón,et al.  HIV-1 infection downregulates nuclear telomerase activity on lymphoblastoic cells without affecting the enzymatic components at the transcriptional level. , 2006, AIDS research and human retroviruses.

[20]  M. Lako,et al.  Overexpression of Telomerase Confers Growth Advantage, Stress Resistance, and Enhanced Differentiation of ESCs Toward the Hematopoietic Lineage , 2005, Stem cells.

[21]  T. Cech.  Beginning to Understand the End of the Chromosome , 2004, Cell.

[22]  Yunkai Yu,et al.  Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex , 2003, Science.

[23]  M. Malim,et al.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif , 2003, Nature Medicine.

[24]  M. Marin,et al.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation , 2003, Nature Medicine.

[25]  P. Nghiem,et al.  Activation of the ATR-mediated DNA Damage Response by the HIV-1 Viral Protein R* , 2003, Journal of Biological Chemistry.

[26]  A. Badley,et al.  Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. , 2003, The Journal of clinical investigation.

[27]  B. Roques,et al.  NMR structure of the HIV-1 regulatory protein VPR. , 2003, Journal of molecular biology.

[28]  M. Blasco,et al.  Cooperation between p53 Mutation and High Telomerase Transgenic Expression in Spontaneous Cancer Development , 2002, Molecular and Cellular Biology.

[29]  Robert A. Weinberg,et al.  Telomerase contributes to tumorigenesis by a telomere length-independent mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. DePinho,et al.  Constitutive telomerase expression promotes mammary carcinomas in aging mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Bostik,et al.  Effect of productive in vitro human immunodeficiency virus or simian immunodeficiency virus infection on telomerase activity in lymphoid and nonlymphoid cells. , 2002, The Journal of infectious diseases.

[32]  L. Chieco‐Bianchi,et al.  Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes. , 2001, The Journal of infectious diseases.

[33]  D. Thomas,et al.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.

[34]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[35]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[36]  N. Saksena,et al.  Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. , 1996, Virology.

[37]  O. Narayan,et al.  Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. , 1994, The Journal of biological chemistry.

[38]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[39]  E. Blackburn,et al.  Functional evidence for an RNA template in telomerase. , 1990, Science.